We are delighted to introduce you to our new RSC Pharmaceutics Editorial Board member, Professor Arvind Kumar Bansal.
Professor Bansal is currently a Dean and Professor at the Department of Pharmaceutics at the National Institute of Pharmaceutical Education and Research (NIPER) – SAS Nagar, Punjab, India.
“I am honoured and excited for my new role as Editorial Board Member of RSC Pharmaceutics. The journal shall capture cutting-edge advancements in the diverse domains of drug delivery and pave the way for better medicines. I look forward to working with the highly accomplished editorial team.”
Read more about Professor Bansal here.
Read some of Professor Bansal’s research:
Study on Sulfamethoxazole–Piperazine Salt: A Mechanistic Insight into Simultaneous Improvement of Physicochemical Properties
Parag Roy, Soumalya Chakraborty, Noopur Pandey, Nimmy Kumari, Sourav Chougule, Amrita Chatterjee, Kaberi Chatterjee, Pallab Mandal, Bapi Gorain, Ananta V. Dhotre, Arvind Kumar Bansal, Animesh Ghosh
Molecular Pharmaceutics, 2023, 20, 5226-5239
Pharmaceutical nanocrystals: A promising approach for improved topical drug delivery
Prashantkumar K. Parmar, Jhanvi Wadhawan, Arvind K. Bansal
Drug Discovery Today, 2021, 10, 2329-2349
RSC Pharmaceutics is a new gold open access journal from the Royal Society of Chemistry and publishes research focused on formulating a drug into a medicine, with the intention of achieving controllable drug delivery with high efficacy. This journal is now open for submissions.
Check out our author guidelines for information on our article types or find out more about the advantages of publishing in a Royal Society of Chemistry journal.
Keep up to date with our latest news by following us on LinkedIn. You can also keep informed by signing up to our E-Alerts.